Breakthrough alzheimer’s and parkinson’s research recognised
Queensland’s Dr Rebecca Coll has been recognised by Australia’s peak medical research body for breakthrough research that could help treat incurable diseases like Alzheimer’s and Parkinson’s.
Research Australia has recognised Dr Coll, a researcher at The University of Queensland’s Institute for Molecular Bioscience, for her role in discovering promising anti-inflammatory compounds that block the NLRP3 inflammasome, a key driver of inflammation.
The NLRP3 inflammasome is a mediator in diseases such as Type 2 diabetes, Alzheimer’s, Parkinson’s, gout, multiple sclerosis and atherosclerosis.
